Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRE: Long-Term rFVIIIFc in Hemophilia A
NCT01454739Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2011
- Primary completion
- Oct 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 22
01
Overview
A Phase 3 trial of eftrenonacog alfa in hemophilia A, sponsored by Sanofi. Started Dec 2011; status: completed.
02
Drugs
eftrenonacog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01454739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01454739.